Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Clinical and Translational Pathology is Scopus-indexed (Q2, CiteScore 2.1), WoS ESCI. Published by Xia and He Publishing Inc..
Checked against the index lists dated .
ISSN 2771-165XVerify ISSN ↗2993-5202Verify ISSN ↗
Publisher: Xia and He Publishing Inc.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 294 / 597 | 50th | Q2 |
| Pathology and Forensic Medicine | 124 / 209 | 40th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 2.1.
Journal of Clinical and Translational Pathology is Q2 in Surgery (rank 294 of 597) and Q3 in Pathology and Forensic Medicine (rank 124 of 209), by CiteScore 2025.
Journal of Clinical and Translational Pathology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.1, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.425, quartile Q2, with an H-index of 7.
Journal of Clinical and Translational Pathology is published by Xia and He Publishing Inc. Its print ISSN is 2771-165X and its online ISSN is 2993-5202.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Clinical and Translational Pathology has an h-index of 9 and a 2-year mean of 0.91 citations per paper (OpenAlex). Its Scopus CiteScore is 2.1, quartile Q2. On 2-year citations it ranks #310 of 585 Scopus journals in Surgery.
Journal of Clinical and Translational Pathology published 25 papers in 2025; its busiest recent year was 2022 with 26. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2022–2026), authors are most often from United States (71.8%), China (9.7%) and Pakistan (4.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.